MONDAY, Feb. 15, 2021 (HealthDay News) — For mother and father with questions on COVID-19 vaccines and youngsters, Johns Hopkins Medicine consultants supply solutions.
While vaccinations for adults are underway within the United States, medical trials for the primary U.S. Food and Drug Administration-authorized COVID-19 vaccines have not but been accomplished for kids and youths youthful than 16.
Before that age group can obtain a vaccine, the FDA and U.S. Centers for Disease Control and Prevention should settle for medical trial outcomes exhibiting the vaccines are secure and efficient in children, defined Dr. Aaron Milstone, a professor of pediatrics at Hopkins’ School of Medicine, and Dr. Kawsar Talaat, assistant professor on the Bloomberg School of Public Health, in Baltimore.
At this time, Pfizer’s COVID-19 vaccine has FDA approval to be used in individuals 16 and older, whereas youngsters aged 12 to fifteen have been enrolled in medical trials of the vaccine.
The Moderna vaccine has FDA approval to be used in individuals 18 and older, whereas youngsters aged 12 to 17 are being enrolled in trials of the vaccine.
COVID-19 vaccines for kids older than 12 years could also be approved by late spring or early summer time, however it could be late 2021 or 2022 earlier than vaccines are approved for these youthful than 12, the docs mentioned.
When youngsters can truly get vaccinated will rely on the vaccine provide, the consultants famous in a Hopkins news launch. Currently, vaccines are being distributed to teams of individuals based mostly on precedence.
Until children can get vaccinated, mother and father ought to defend their youngsters from COVID-19 by persevering with to follow prevention measures, reminiscent of sporting face masks, sustaining secure bodily distance from others and by training applicable hand hygiene, Milstone and Talaat suggested.
The American Academy of Pediatrics has extra on COVID-19.
SOURCE: Johns Hopkins Medicine, news launch, Feb. 9, 2021